4th Quarter - Report

MEHLMAN CONSULTING, INC. for AEGIS SCIENCES CORPORATION

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare contractor issues related to coverage and reimbursement for drugs of abuse testing. Access to COVID-19 laboratory testing. H.R. 9747 (Pub. L. 118-83) - Continuing Appropriations and Extensions Act, 2025. Protecting Access to Medicare Act (PAMA) - Delaying laboratory payment reductions. H.R. 10545 - The American Relief Act.

Contacted: SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 10545 (118th), H.R. 9747 (118th)

Health Issues HCR

Access to COVID-19 laboratory testing.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.